Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13
Zhong Chen(Sun Yat-sen University), Qianben Wang(The University of Texas at San Antonio Health Science Center), Emmanuel S. Antonarakis(University of Minnesota), Pearlly S. Yan(The Ohio State University), Jiaoti Huang(Space Science Institute), Pei Zhao(Johns Hopkins University), Tim H.‐M. Huang(UNSW Sydney), Changxue Lu(Johns Hopkins University), Connor M. Geraghty(The Ohio State University), Victor X. Jin(The Ohio State University), Jennifer M. Thomas‐Ahner(The Ohio State University), Dayong Wu(Shihezi University), Jun Luo(Johns Hopkins University), Benjamin Sunkel(The Ohio State University), Zhihua Liu(Shanghai Jiao Tong University), Qingfu Zhang(Duke University), Xiaolong Cheng(The University of Texas at San Antonio Health Science Center), William Hankey(Duke University), Qi-En Wang(Duke University), Steven K. Clinton(The Ohio State University)
Cited by 163
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
|The Journal of Clinical Endocrinology & Metabolism|2010|4k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k